Active substance
Results for the substance diphtheria+tetanus+pertussis+hepatitis b vaccine+haemophilus influenzae type b
1 result
About this active substance
The combined diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type B (DTP-HepB-Hib) vaccine is used to prevent five serious infectious diseases: diphtheria, tetanus, whooping cough (pertussis), hepatitis B, and infections caused by Haemophilus influenzae type B. The vaccine contains diphtheria and tetanus toxoids, inactivated or purified components of Bordetella pertussis, hepatitis B surface antigen, and conjugated capsular polysaccharides of Haemophilus influenzae type B.
The vaccine is administered intramuscularly, usually in multiple doses, according to recommended vaccination schedules for infants and young children. This combined vaccine reduces the number of required injections, facilitating adherence to the vaccination schedule.
Common side effects include pain at the injection site, mild fever, fatigue, and irritability. In rare cases, severe allergic reactions may occur.
The DTP-HepB-Hib vaccine is an essential measure for protecting public health, helping to reduce the incidence and severity of these infectious diseases and prevent the severe complications associated with them.
The vaccine is administered intramuscularly, usually in multiple doses, according to recommended vaccination schedules for infants and young children. This combined vaccine reduces the number of required injections, facilitating adherence to the vaccination schedule.
Common side effects include pain at the injection site, mild fever, fatigue, and irritability. In rare cases, severe allergic reactions may occur.
The DTP-HepB-Hib vaccine is an essential measure for protecting public health, helping to reduce the incidence and severity of these infectious diseases and prevent the severe complications associated with them.